Page last updated: 2024-10-30

lorglumide and Osteosarcoma

lorglumide has been researched along with Osteosarcoma in 1 studies

lorglumide: RN given refers to (+-)-isomer
lorglumide : A racemate comprising equal amounts of (R)- and (S)-lorglumide.
N(2)-(3,4-dichlorobenzoyl)-N,N-dipentyl-alpha-glutamine : A dicarboxylic acid monoamide obtained by formal condensation of the alpha-carboxy group of N-(3,4-dichlorobenzoyl)glutamic acid with the amino group of dipentylamine.

Osteosarcoma: A sarcoma originating in bone-forming cells, affecting the ends of long bones. It is the most common and most malignant of sarcomas of the bones, and occurs chiefly among 10- to 25-year-old youths. (From Stedman, 25th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sturzu, A1
Sheikh, S1
Klose, U1
Echner, H1
Kalbacher, H1
Deeg, M1
Nägele, T1
Horger, M1
Schwentner, C1
Ernemann, U1
Heckl, S1

Other Studies

1 other study available for lorglumide and Osteosarcoma

ArticleYear
Potential of the gastric motility drug lorglumide in prostate cancer imaging.
    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2012, Apr-11, Volume: 45, Issue:5

    Topics: Cell Line, Tumor; Contrast Media; Flow Cytometry; Fluorescent Dyes; Gastrointestinal Agents; Gastroi

2012